| Financial Year |
March 31 2023 |
| Monetary Funds |
140,309,563.48 |
| Held-for-trading Financial Assets |
140,000,000.00 |
| Notes Receivable |
25,636,629.20 |
| Accounts Receivable |
347,426,970.88 |
| Advances to Suppliers |
31,390,120.54 |
| Other Receivables |
2,279,905.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
329,619,540.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
853,076.98 |
| Total Current Assets |
1,017,515,806.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
163,401,794.45 |
| Under-construction Projects |
7,170,081.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,519,545.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
61,190.63 |
| Deferred Income Tax Assets |
10,578,741.79 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
204,390,675.57 |
| Total Assets |
1,221,906,482.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,068,662.65 |
| Accounts Payable |
151,466,700.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,368,568.92 |
| Taxes Payable |
3,208,919.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
138,738.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
545,746.69 |
| Other Current Liabilities |
2,141,910.11 |
| Sub-Total of Current Liabilities |
199,737,455.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
794,493.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,474,156.02 |
| Total Liabilities |
202,211,611.66 |
| Paid-In Capital(Or Share Stock) |
323,593,851.00 |
| Capital Surplus |
237,149,388.45 |
| Surplus Reserve |
50,408,797.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
387,809,368.27 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,019,694,870.84 |
| Owner's Equity（Stockholder's Equity） |
1,019,694,870.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,221,906,482.50 |
